顯示第 1 至 16 項結果，共 38 項
-
Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] (Ab00190-1.1-BT)
-
Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] (Ab00190-1.1)
-
Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] (Ab00190-8.1-BT)
-
Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] (Ab00190-8.1)
-
Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] (Ab00190-8.4-BT)
-
Anti-CD11 alpha/Integrin alpha-L [YTH 81.5] (Ab00190-8.4)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-1.1-BT)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-1.1)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.0-BT)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.0)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.3-BT)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.3)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.6-BS)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.6-BT)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-10.6)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-2.0-BT)